PhoenixBio Co., Ltd.

¥244.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:6190Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (19.27%)
Div yield —
ROE 1.06%
Biotechnology
Beta (5Y) 0.34
PE TTM 66.20
TSR TTM (54.14%)
Mkt cap ¥993.1M
ROIC (3.23%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥291
19.32%
299.45%
Hold 0|3|9|11|4
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
5.94
6.26
6.69
6.75
23.54%
35.38%
36.90%
27.09%
Revenue¥M
114.5
117.2
115.1
114.5
16.44%
16.67%
10.90%
4.41%
Peers (US$6.306M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.734
0.958
0.661
EBIT/Intx
1.471
0.581
0.569
Own earn%
(48.14)
(49.08)
(5.89)
Sh yield%
36.12
41.80
38.94
Owners
Insiders/Inst%
9.16
51.23
Short interest%
5.81
SBC / revenue%
3.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
0–10
$1 testx
0.0
Incr. ROIC%
10